Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia
Background: Peripheral blood mononuclear cells (PBMNCs) showed encouraging short outcomes in the treatment of angiitis-induced no-option critical limb-threatening ischemia (AICLTI) in the pilot study. This study aimed to demonstrate the long-term outcomes of this treatment.Methods: From May 2014 to...
Main Authors: | Xiaolang Jiang, Hao Liu, Tianyue Pan, Shiyang Gu, Yuan Fang, Zheng Wei, Gang Fang, Bin Chen, Junhao Jiang, Yun Shi, Peng Liu, Weiguo Fu, Zhihui Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.769472/full |
Similar Items
-
Three‐year outcomes of peripheral blood mononuclear cells vs purified CD34+ cells in the treatment of angiitis‐induced no‐option critical limb ischemia and a cost‐effectiveness assessment: A randomized single‐blinded noninferiority trial
by: Hao Liu, et al.
Published: (2021-05-01) -
Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience
by: Gang Fang, et al.
Published: (2020-10-01) -
The peripheral blood mononuclear cells versus purified CD34+ cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis—a randomized single-blinded non-inferiority trial
by: Hao Liu, et al.
Published: (2022-03-01) -
Return to work after cell transplantation in patients with angiitis-induced critical limb ischaemia and factors related: a single-centre retrospective cohort study
by: Hao Liu, et al.
Published: (2022-04-01) -
Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia
by: Tianyue Pan, et al.
Published: (2019-01-01)